| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 07/07/2005 | US20050147987 Polymorphisms in known genes associated with type II diabetes and obesity, methods of detection and uses thereof |
| 07/07/2005 | US20050147985 Mixtures of isobarically labeled analytes and fragments ions derived therefrom |
| 07/07/2005 | US20050147984 Interaction detection on several probe arrays |
| 07/07/2005 | US20050147982 Mixtures of isobarically labeled analytes and fragments ions derived therefrom |
| 07/07/2005 | US20050147628 Dna encoding novel cyclic gmp dependent protein kinases from two protozoal sources for use as chemotherapeutic targets for antiprotozoal agents |
| 07/07/2005 | US20050147621 Use of bacterial 5' untranslated regions for nucleic acid expression |
| 07/07/2005 | US20050147610 Polypeptides comprising antigen binding domains for diagnosis, prevention and treatment of inflammation, skin, respiratory, kidney, cardiovascular, nervous system and pancreatic disorder |
| 07/07/2005 | US20050147604 Means and methods for diagnosing and treating affective disorders |
| 07/07/2005 | US20050147601 Angiogenesis inhibitor; wound healing agents; prevent cell adhesion in mallals |
| 07/07/2005 | CA2551190A1 Polypeptides for modulating binding of trp channel proteins and trp-associated proteins. |
| 07/07/2005 | CA2550258A1 Oligomeric compounds for the modulation of bcl-2 |
| 07/07/2005 | CA2549720A1 Cell transfecting formulations of small interfering rna, related compositions and methods of making and use |
| 07/07/2005 | CA2548205A1 Double stranded linear nucleic acid probe and uses thereof |
| 07/07/2005 | CA2548065A1 Anti-igf-i receptor antibody |
| 07/07/2005 | CA2522421A1 Methods of therapy and diagnosis using targeting of cells that express killer cell immunoglobulin-like receptor-like protein |
| 07/06/2005 | EP1549772A2 Methods and compositions for detection and analysis of polynucleotides using light harvesting multichromophores |
| 07/06/2005 | EP1549763A2 Prophylactic and therapeutic hiv aptamers |
| 07/06/2005 | EP1549762A1 Methods for the enrichment of low-abundance polynucleotides |
| 07/06/2005 | EP1549761A1 Methods and compositions for the modification of nucleic acids |
| 07/06/2005 | EP1549755A2 Spliceosome mediated rna trans-splicing in stem cells |
| 07/06/2005 | EP1549746A1 Tryptophan as a functional replacement for adp-ribose-arginine in recombinant proteins |
| 07/06/2005 | EP1549671A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 07/06/2005 | EP1549662A1 Methods for the chemical and physical modification of nanotubes, methods for linking the nanotubes, methods for the directed positioning of nanotubes, and uses thereof |
| 07/06/2005 | EP1549660A2 RNA INTERFERENCE MEDIATED INHIBITION OF GRB2-ASSOCIATED BINDING PROTEIN 2 (GAB2) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 07/06/2005 | EP1549324A1 Composition and method to whiten skin |
| 07/06/2005 | EP1423535A4 Haplotype map of the human genome and uses therefor |
| 07/06/2005 | EP1162982B9 USE OF STABILISED OLIGONUCLEOTIDES FOR PREPARING A MEDICament WITH ANTITUMOUR ACTIVITY |
| 07/06/2005 | EP1060264B1 Dideoxy dye terminators |
| 07/06/2005 | CN1636060A Methods of delivery of exogenous proteins to the cytosol and uses thereof |
| 07/06/2005 | CN1636058A Novel alanine transaminase enzyme and methods of use |
| 07/06/2005 | CN1634978A SARS virus HLA-A2 limited epitope polypeptide and uses thereof |
| 07/06/2005 | CN1634966A Process for simultaneously carrying out RNA and DNA extraction from clinical samples by employing virus cracking liquid and precipitation process |
| 07/06/2005 | CN1634965A Process for extracting DNA from biological samples |
| 07/06/2005 | CN1634964A Medicinal herb solvent extract for treating hepatic disease |
| 07/06/2005 | CN1634963A Coronary disease related gene, its detection method and use thereof |
| 07/06/2005 | CN1634962A Process for preparing synergy factor in artificial blood, nucleotide sequence used thereby |
| 07/06/2005 | CN1209374C Human Protein for promoting transform of 3T3 cell and its coding sequence |
| 07/06/2005 | CN1209373C Human protein with suppression to cancer cell growth and its coding sequence |
| 07/06/2005 | CN1209370C New human protein with cancer inhibiting function and its encoding sequence |
| 07/06/2005 | CN1209369C Cell death inducing protein and its coding sequence and use |
| 07/06/2005 | CA2452131A1 Use of untranslated region of osmotin gene to enhance transgene expression in plants |
| 07/05/2005 | US6914148 Monomer for use in huaman therapeutics and diagnostics |
| 07/05/2005 | US6914137 Adjustment of pH |
| 07/05/2005 | US6913892 Method of obtaining compositions comprising Y4 specific compounds |
| 07/05/2005 | US6913880 Method for determining transcription factor activity and its technical uses |
| 07/05/2005 | CA2129663C Biosynthetic binding protein for cancer marker |
| 06/30/2005 | WO2005059182A2 Reagents and methods for detecting neisseria gonorrhoeae |
| 06/30/2005 | WO2005059180A1 Methods of attaching oligonucleotides and peptides to solid supports using 2,4-hydrazin- (1, 3, 5) triazine-activated solid phases |
| 06/30/2005 | WO2005059159A2 Dna polymerase compositions for quantitative pcr and methods thereof |
| 06/30/2005 | WO2005059157A2 METHODS AND COMPOSITIONS FOR USE IN PREPARING HAIRPIN RNAs |
| 06/30/2005 | WO2005059131A2 Protein binding miniature proteins and uses thereof |
| 06/30/2005 | WO2005059102A2 METHOD FOR OBTAINING AN ENRICHED POPULATION OF siRNA-EXPRESSING CELLS |
| 06/30/2005 | WO2005059099A2 Human ipla2t |
| 06/30/2005 | WO2005058957A2 Ztnf 12, a tumor necrosis factor |
| 06/30/2005 | WO2005058952A2 Ztnf13, a tumor necrosis factor |
| 06/30/2005 | WO2005058946A2 Methods for enhancing expression of recombinant proteins |
| 06/30/2005 | WO2005058938A2 Helical synthetic peptides that stimulate cellular cholesterol efflux |
| 06/30/2005 | WO2005058933A1 Formulations and methods for denaturing proteins |
| 06/30/2005 | WO2005058479A2 Methods for synthesis of encoded libraries |
| 06/30/2005 | WO2005058369A2 Compositions of l-caldesmon for treating viral infection |
| 06/30/2005 | WO2005044989A3 Polynucleotides and polypeptides of anaplasma phagocytophilum and methods of using the same |
| 06/30/2005 | WO2005042704A3 Differential enzymatic fragmentation |
| 06/30/2005 | WO2005042560A3 Non-viral delivery of compounds to mitochondria |
| 06/30/2005 | WO2005037218A3 Lentiviral vector delivery of il-21 for treatment of cancer |
| 06/30/2005 | WO2005030027A3 Salmonella detection identification |
| 06/30/2005 | WO2005028617A3 Antisense inhibition of laminin-8 expression to inhibit human gliomas |
| 06/30/2005 | WO2005021725A3 Nucleic acid analysis method conducted in small reaction volumes |
| 06/30/2005 | WO2005009369A3 A ca6 antigen-specific cytotoxic conjugate and methods of using the same |
| 06/30/2005 | WO2004111072A3 Combinatorial nucleobase oligomers comprising universal base analogues and methods for making and using same |
| 06/30/2005 | WO2004099385A3 Telomere elongation |
| 06/30/2005 | WO2004093788A3 Desmoglein 4 is a novel gene involved in hair growth |
| 06/30/2005 | WO2004061127A3 Hybridization-based biosensor containing hairpin probes and use thereof |
| 06/30/2005 | WO2004061117A3 Compositions and methods for enzymatic detachment of bacterial and fungal biofilms |
| 06/30/2005 | WO2004054502A3 Modulation of tek expression |
| 06/30/2005 | WO2004048938A3 Methods of detecting soft tissue sarcoma, compositions and methods of screening for soft tissue sarcoma modulators |
| 06/30/2005 | WO2004035611A3 Peptides binding the phosphatase 2a protein and polynucleotides encoding same |
| 06/30/2005 | WO2004002424A8 Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses |
| 06/30/2005 | WO2003062389A3 UNIVERSAL RT-COUPLED PCR METHOD FOR THE SPECIFIC AMPLIFICATION OF mRNA |
| 06/30/2005 | US20050144669 MicroRNAs in plants |
| 06/30/2005 | US20050144109 Electronic trading data integration and protection system |
| 06/30/2005 | US20050143337 Nucleic acid-based compounds and methods of use thereof |
| 06/30/2005 | US20050143335 Oligonucleotides, targeted to nucleic acids encoding Survivin; cancer |
| 06/30/2005 | US20050143333 RNA interference mediated inhibition of interleukin and interleukin receptor gene expression using short interfering nucleic acid (SINA) |
| 06/30/2005 | US20050143332 Delivering a siRNA to a mammal cell; low toxicity |
| 06/30/2005 | US20050143287 Ischemic heart disease, critical limb ischemia, wound healing and burns, cancer, diabetic retinopathy, and inflammatory diseases such as arthritis and psoriasis |
| 06/30/2005 | US20050142637 Long-wavelength FPs |
| 06/30/2005 | US20050142617 gene related to bone density; possible use in the drug screening, treatment, and diagnosis of bone disorders such as osteoporosis |
| 06/30/2005 | US20050142610 domains peptides having increased or decreased binding specificity for phosphatides, used as controls in bioassays to detect the presence of specific phosphatides |
| 06/30/2005 | US20050142607 Contacting biological sample with at least two antibodies wherein epitope in Moraxella catarrhalis for each antibody is either internal or surface exposed and detecting binding of antibodies to sample, wherein binding is indicative of presence of Moraxella catarrhalis; bacteria-induced acute otitis media |
| 06/30/2005 | US20050142600 Protein modification and maintenance molecules |
| 06/30/2005 | US20050142598 Oligonucleotides containing molecular rods |
| 06/30/2005 | US20050142595 Analyzing nucleic acid by contacting with intercalator fluorophore and sequence specific probe capable of hybridizing to nucleic acid, wherein probe is labeled with probe fluorophore, and detecting fluorescence resonance energy transfer between intercalator fluorophore and probe fluorophore |
| 06/30/2005 | US20050142592 Nucleotide sequences coding proteins for use in diagnosis and treatment of tumors; prostate cancer antigen diagnostic marker 1 (PCADM-1) |
| 06/30/2005 | US20050142582 Aptamers and methods for their in vitro selection and uses thereof |
| 06/30/2005 | US20050142580 Methods and probes for diagnosing a gynaecological condition |
| 06/30/2005 | US20050142570 Methods for nucleic acid isolation and kits using a microfluidic device and sedimenting reagent |
| 06/30/2005 | US20050142569 Using inflammatory marker gene expression to diagnose arthritis |
| 06/30/2005 | US20050142564 Forward and reverse primers; generation of plant population with high content of artemisinin |
| 06/30/2005 | US20050142561 Intracellular signaling pathways in diabetic subjects |
| 06/30/2005 | US20050142560 Method for identifying and managing livestock by genotype |